Safety and tolerability of rizatriptan.
Sakai
F
F
Department of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan. fsakai@kitasato-u.ac.jp
D016907:Adverse Drug Reaction Reporting Systems; D002986:Clinical Trials as Topic; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D017366:Serotonin Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use; D014363:Tryptamines
D017366:Serotonin Receptor Agonists; D014230:Triazoles; D014363:Tryptamines; C093622:rizatriptan